Cellectar Biosciences (NASDAQ:CLRB) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) in a report issued on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Cellectar Biosciences Stock Performance Shares of CLRB stock opened at $0.27 on Monday. The company has a market capitalization of $12.26 million, a price-to-earnings ratio of […]
StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) in a report issued on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Cellectar Biosciences Stock Performance Shares of CLRB stock opened at $0.27 on Monday. The company has a market capitalization of $12.26 million, a price-to-earnings ratio of […]
